Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Medicinal Research Reviews|May 22, 2023
New drug approvals for 2022: Synthesis and clinical applicationsShuo Yuan, Dan-Dan Shen, Rui Jia, et al.Frontiers in Oncology|January 11, 2021
Non-Invasive Estimation of Glioma <i>IDH1</i> Mutation and <i>VEGF</i> Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRIYue Hu, Yue Chen, Jie Wang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 18, 2024
KIF2C: An important factor involved in signaling pathways, immune infiltration, and DNA damage repair in tumorigenesisRui-Qing Li, Yan Yang, Lin Qiao, et al.European Journal of Radiology|December 31, 2016
Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculatureZhong Zheng Jia, Wei Shi, Jin Long Shi, et al.Medicinal Research Reviews|August 24, 2024
The recent advance and prospect of poly(ADP-ribose) polymerase inhibitors for the treatment of cancerYi-Ru Bai, Wei-Guang Yang, Rui Jia, et al.Pharmaceutical Biology|November 5, 2019
Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1Dan-Dan Shen, Zhong-Hui Yang, Ji Huang, et al.Molecules (Basel, Switzerland)|March 15, 2020
Phenolic Compounds, Antioxidant Activities, and Inhibitory Effects on Digestive Enzymes of Different Cultivars of Okra (<i>Abelmoschus esculentus</i>)Ding-Tao Wu, Xi-Rui Nie, Dan-Dan Shen, et al.Academic Radiology|November 13, 2018
Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRIJia Shen Jiang, Ye Hua, Xue Jun Zhou, et al.Journal of Pharmaceutical and Biomedical Analysis|September 17, 2018
Development of formaldehyde dehydrogenase-coupled assay and antibody-based assays for ALKBH5 activity evaluationDan-Dan Shen, Feng-Zhi Suo, Qi-Meng Song, et al.International Immunopharmacology|June 8, 2024
Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriersMaa Mamun, Yi-Chao Zheng, Ning Wang, et al.Pageof 8